Immune responses against Factor VIII, which is used to treat hemophilia A (bleeding disorder), are influenced by the microenvironment of antigen presenting cells. This is the result of a scientific study conducted in cooperation ...
Nov 22, 2022
0
14
Researchers led by Osaka University have now identified a mechanism by which a lack of insulin may be reported back to the pancreatic cells that produce insulin, identifying a potential new therapeutic target for diabetes.
Nov 7, 2022
0
4
Engineered particles of purified sand could be the next anti-obesity therapy as new research from the University of South Australia shows that porous silica can prevent fats and carbohydrates from being adsorbed in the body.
Oct 24, 2022
0
14
Investigators have designed an antibody-based treatment that eliminated circulating tumor cells (CTCs) in mouse models of breast and pancreatic cancer. The research, which was led by scientists at Massachusetts General Hospital ...
Oct 20, 2022
0
50
NeuroOmics technology lets researchers label and capture cell-surface proteins in intact, live tissue—opening opportunities to understand complex cellular interactions and future drug targets.
Oct 19, 2022
0
82
An entirely new approach to monoclonal antibody therapy shows that targeting the more genetically stable internal protein of the SARS-CoV-2 virus rather than the surface spike protein can also clear SARS-CoV-2, reports a ...
Oct 14, 2022
0
60
Scientists have solved a long-standing mystery surrounding a cancer-promoting protein and how it causes tumor growth. The findings are an important step in the quest to make cancer drugs more effective since aggressive tumors ...
Oct 12, 2022
0
14
Non-invasive sensors laid on the skin's surface to measure bioelectrical activity could offer a better alternative for patients suffering with poor gut health.
Sep 29, 2022
0
40
Everyone with good vision knows the difference between a bright and dark day. In a bright day, the sky forms a homogeneous blue surface that can reflect as much as 30,000 cd/m2 of light whereas, in a dark day, the clouds ...
Sep 27, 2022
0
0
A device known as the BASHIR Endovascular Catheter (THROMBOLEX, Inc.) significantly reduces the size of blood clots lodged in the pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism, ...
Sep 19, 2022
0
5
